Oxford Biomedica, (OXB),...............time to buy.

KDC... If, as news suggests, you're posting negative comments about OXB without knowing anything about the company I'm not surprised people are objecting and am very glad to hear ADVFN are at last doing something about this practise.

Whilst I agree entirely that both sides of any argument should be heard, I don't think that should include knocking a share for the sake of driving the price down unless you can back up your suggestion that the price is higher than it should be - and back it up with facts and your sources.